Clover Health Investments (CLOV) Projected to Post Quarterly Earnings on Tuesday

Clover Health Investments (NASDAQ:CLOV) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 11th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $346.92 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Clover Health Investments Stock Down 8.3 %

Shares of Clover Health Investments stock opened at $3.64 on Tuesday. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.87. The business has a fifty day simple moving average of $4.05 and a 200 day simple moving average of $3.60. The stock has a market cap of $1.82 billion, a PE ratio of -18.20 and a beta of 1.99.

Analyst Ratings Changes

CLOV has been the subject of a number of analyst reports. Canaccord Genuity Group lifted their price objective on Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a research note on Monday. Craig Hallum initiated coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective for the company.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.